Publications by authors named "Joe Ensor"

Claim this Profile
M
Molecular response cutoffs and ctDNA collection timepoints influence on interpretation of associations between early changes in ctDNA and overall survival in patients treated with anti-PD(L)1 and/or chemotherapy.
Hillary S Andrews, Nevine Zariffa, Katherine K Nishimura, Yu Deng, Megan Eisele, Joe Ensor

J Immunother Cancer· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum: Analysis of the Implementation of Telehealth Visits for Care of Patients With Cancer in Houston During the COVID-19 Pandemic.
Jorge G Darcourt, Kalia Aparicio, Phillip M Dorsey, Joe E Ensor, Eva M Zsigmond

JCO Oncol Pract· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hydroxytyrosol, a Component of Olive Oil for Breast Cancer Prevention in Women at High Risk of Cancer.
Akshjot Puri, Zheng Yin, Sergio Granados-Principal, Joe Ensor, Liliana Guzman

Int J Breast Cancer· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heparin-induced thrombocytopenia with very high antibody titer is associated with slower platelet recovery and higher risk of thrombosis.
Akash Mukherjee, Cesar Gentille, Asmita Patel, Joe Ensor, Lawrence Rice

Int J Hematol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trial Protocol of a Phase II Study of mFOLFOXIRI after Metastasectomy in Patients with Oligometastatic Colorectal Cancer (FANTASTIC Study).
Kozo Kataoka, Takeshi Yamada, Kentaro Yamazaki, Keita Mori, Nobuhisa Matsuhashi, Joe Ensor

J Anus Rectum Colon· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Deep Learning Decision Support Tool to Improve Risk Stratification and Reduce Unnecessary Biopsies in BI-RADS 4 Mammograms.
Chika F Ezeana, Tiancheng He, Tejal A Patel, Virginia Kaklamani, Maryam Elmi, Joe Ensor

Radiol Artif Intell· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 2 Trial of Enhancing Immune Checkpoint Blockade by Stereotactic Radiation and In Situ Virus Gene Therapy in Metastatic Triple-Negative Breast Cancer.
Kai Sun, Yitian Xu, Licheng Zhang, Polly Niravath, Jorge Darcourt, Joe Ensor

Clin Cancer Res· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BESPOKE IO protocol: a multicentre, prospective observational study evaluating the utility of ctDNA in guiding immunotherapy in patients with advanced solid tumours.
Pashtoon Murtaza Kasi, Sakti Chakrabarti, Sarah Sawyer, Michael Krainock, Andrew Poklepovic, Joe Ensor

BMJ Open· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Impact of the Use of C-Arm Cone-Beam CT During Chemoembolization for Hepatocellular Carcinoma.
Mohamed E Abdelsalam, Tomas M A Figueira, Joe Ensor, Alda L Tam, Rony Avritscher

Curr Med Imaging· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1/2 clinical trial of the nitric oxide synthase inhibitor L-NMMA and taxane for treating chemoresistant triple-negative breast cancer.
Andrew W Chung, Kartik Anand, Ann C Anselme, Alfred A Chan, Nakul Gupta, Joe Ensor

Sci Transl Med· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary diffuse large B-cell lymphoma of the uterus: A SEER database analysis.
Allyne M Ensor, Cesar Gentille Sanchez, Joe E Ensor, Kartik Anand

Medicine (Baltimore)· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes and prognostic contributors in patients with mutated non-small cell pulmonary adenocarcinomas: a single institution experience.
Ethan A Burns, Joe E Ensor, Jim Hsu, Jessica S Thomas, Randall J Olsen

J Thorac Dis· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of efficacy and safety of pegfilgrastim when given less than two weeks from dose-dense chemotherapy regimens.
Godsfavour O Umoru, Hanna Zaghloul, Cynthia El-Rahi, Joe E Ensor

J Oncol Pharm Pract· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ANETT: PhAse II trial of NEoadjuvant TAK-228 plus Tamoxifen in patients with hormone receptor-positive breast cancer.
Emre Koca, Polly Ann Niravath, Joe Ensor, Tejal Amar Patel, Xiaoxian Li

Breast Cancer Res Treat· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiac Failure Because of Osimertinib.
Kartik Anand, Joe Ensor

J Clin Oncol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase II Study of the Efficacy and Safety of Chloroquine in Combination With Taxanes in the Treatment of Patients With Advanced or Metastatic Anthracycline-refractory Breast Cancer.
Kartik Anand, Polly Niravath, Tejal Patel, Joe Ensor, Angel Rodriguez

Clin Breast Cancer· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
G6PD deficiency and severity of COVID19 pneumonia and acute respiratory distress syndrome: tip of the iceberg?
Jihad G Youssef, Faisal Zahiruddin, George Youssef, Sriram Padmanabhan, Joe Ensor

Ann Hematol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Randomized Phase II Study of Sequential Eribulin Versus Paclitaxel Followed by FAC/FEC as Neoadjuvant Therapy in Patients with Operable HER2-Negative Breast Cancer.
Bora Lim, Juhee Song, Nuhad K Ibrahim, Kimberly B Koenig, Mariana Chavez-MacGregor, Joe E Ensor

Oncologist· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of the Implementation of Telehealth Visits for Care of Patients With Cancer in Houston During the COVID-19 Pandemic.
Jorge G Darcourt, Kalia Aparicio, Phillip M Dorsey, Joe E Ensor, Eva M Zsigmond

JCO Oncol Pract· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting mTOR and DNA repair pathways in residual triple negative breast cancer post neoadjuvant chemotherapy.
Kartik Anand, Tejal Patel, Polly Niravath, Angel Rodriguez, Jorge Darcourt, Joe Ensor

Sci Rep· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mycobacterial infections due to PD-1 and PD-L1 checkpoint inhibitors.
Kartik Anand, Geetanjali Sahu, Ethan Burns, Allyne Ensor, Joe Ensor

ESMO Open· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T-cell lymphoma secondary to checkpoint inhibitor therapy.
Kartik Anand, Joe Ensor, Sai Ravi Pingali, Patrick Hwu, Madeleine Duvic

J Immunother Cancer· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mycobacterial Infections With Ruxolitinib: A Retrospective Pharmacovigilance Review.
Kartik Anand, Ethan A Burns, Joe Ensor, Lawrence Rice, Sai Ravi Pingali

Clin Lymphoma Myeloma Leuk· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Osimertinib-Induced Cardiotoxicity: A Retrospective Review of the FDA Adverse Events Reporting System (FAERS).
Kartik Anand, Joe Ensor, Barry Trachtenberg, Eric H Bernicker

JACC CardioOncol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, controlled phase II trial of neoadjuvant ado-trastuzumab emtansine, lapatinib, and nab-paclitaxel versus trastuzumab, pertuzumab, and paclitaxel in HER2-positive breast cancer (TEAL study).
Tejal A Patel, Joe E Ensor, Sarah L Creamer, Toniva Boone, Angel A Rodriguez

Breast Cancer Res· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis